![Graham Hughes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr Graham Hughes, a chemist by training, has broad-based research, development and commercial experience in the chemical, agrochemical and pharmaceutical industries.
He initially worked for ICI and, whilst Development Manager at their European Headquarters in Brussels, was responsible for the in-house laboratory development and field trials of a wide range of speciality chemicals, with applications in cosmetics, pharmaceuticals and agrochemicals.
He was also Toxicology Liaison Officer for ICI Europa.
As Director of Technical and Regulatory Affairs for Zoecon Corporation (Europe) - a Sandoz subsidiary - he was in overall charge of the technical development of animal health products and agrochemicals, from research through to registration.
Graham Hughes was a co-founder of the company in 1987 and is an acknowledged expert on pharmaceutical outsourcing, having intimate familiarity with all aspects of Contract Research Organisations.
He is Chairman of the Editorial Board of European Pharmaceutical Contractor, and an Editorial Adviser to Global Outsourcing Review.
Anciens postes connus de Graham Hughes
| Sociétés | Poste | Fin |
|---|---|---|
Technomark Investment Management Ltd.
 Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | Directeur de la Recherche - Actions | 01/10/2008 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Technomark Investment Management Ltd.
Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | Finance |
